16 out. FARMACOLOGIA CARDIOVASCULAR GRUPO 5. CASO CLÍNICO EXAME FÍSICO No momento da consulta, o exame físico não apresentava. Thank You! Farmacos Antianginosos e hipotensores. Una de las patologías y molestias mas frecuentes de la cardiopatía isquemica. MEDICAMENTOS CARDIOVASCULARES. Antianginosos. ATENOLOL. Comprimido 50 mg. (; ). Comprimido mg.

Author: Tektilar Taujas
Country: Belgium
Language: English (Spanish)
Genre: Education
Published (Last): 18 February 2009
Pages: 417
PDF File Size: 11.98 Mb
ePub File Size: 8.61 Mb
ISBN: 943-4-97953-313-6
Downloads: 73122
Price: Free* [*Free Regsitration Required]
Uploader: Yojin

Acceso el 10 febrero Factores de riesgo para enfermedades cardiovasculares.

Medicamentos de Cardiología. by Sebastian Rodriguez on Prezi

Effective use of combination lipid therapy. The use of a hospital laboratory cohort to estimate the prevalence of dyslipidemia in an adult Bra zilian population. Existe subempleo de antianginosos y ASA y sobreempleo de antiinflamatorios y antiulcerosos.

Of the total number of patients, Cholesterol control, medication adherence and illness cognition. Sanal S, Aronow WS. Vigilancia de los factores de riesgo para enfermedades no transmisibles: ReadCube Visualizar o texto. Effect of an educational program on the prevalence of use of anti platelet drugs, beta blockers, angiotensin-converting enzyme inhibitors, lipid-lowering drugs, and calcium channel blockers prescribed during hospitalization and at hospital discharge in patients with coronary artery disease.

Am J Manag Care. Issues and evidence for the management of dyslipidaemia in primary care. Patrones de uso de antihipertensivos en 11 pacientes colombianos. Consejo Nacional de Seguridad Social en Salud. La dislipidemia es un factor de riesgo primario para desarrollar enfermedad coronaria y accidentes cerebrovasculares, causas frecuentes de morbilidad y mortalidad en Colombia y el mundo.


Update for primary healthcare providers: Br J Health Psychol.

Eur J Gen Pract. Primatesta P, Poulter RN.

Nitroglicerina (fármaco)

Lipid concentrations and the use of lipid lowering drugs: Management of hyperlipidaemia after coronary revascularisation: Dyslipidemia; hyperlipidemia; hypertriglyceridemia; drug therapy, lipid; drugs with prescription; Colombia.

J Manag Care Pharm.

Clearly there is a need for creating educational strategies to address these prescribing habits and for exploring clinical results of the pharmaceuticals studied. Antianginoosos descriptive, observational study was conducted of 41 hyperlipidemics of both sexes, who were over 20 years of age, undergoing treatment from at least April to Juneand were residents of one of 19 cities in Colombia.

Int J Clin Pract ; Las diferencias halladas entre los pacientes tratados con monoterapia versus aquellos que reciben politerapia, se pueden explicar porque existen pocas opciones de medicamentos y algunas asociaciones revisten riesgo. A database was created to track prescription data collected by the pharmaceutical company that dispenses medications to the patients. Prescription patterns for antilipidemic drugs in a group of Colombian patients.


The mean age was Antianginals and ASA were being underused, while antiinflamatories and antiulcer drugs were being overused.

Differences between clinical trial efficacy and real-world effectiveness. Cardiovascular disease and lipids. Dyslipidemia is a primary risk factor for developing coronary heart disease and stroke, frequent causes of morbidity and mortality in Colombia and the world.

To determine patterns in antilipidemic drug prescriptions among a group of patients covered by the General Social Security System Sistema General de Seguridad Social in Colombia. Asimismo, disponen de bases de datos pertinentes y confiables.

Distribution and correlates of lipids and lipoproteins in elderly Japanese-American men. Acuerdo de Comedications most frequently prescribed were: Estas investigaciones contribuyen al uso racional de medicamentos.

Strategies for optimizing treatment outcomes. Arterioscler Thromb Vasc Biol. All of the antilipidemics are being used at lower-than-recommended dosage levels. Prescriptions were ranked as follows: Similares antianglnosos Google Citados no Google Scholar.

Manuscrito recibido el 19 de enero de Recommendations for the management of dyslipidemia and prevention of cardiovascular disease: